Table 3 Laboratory evaluations of active patients, inactive patients and healthy controls at baseline
Active disease (n = 74) | Non active disease (n = 56) | Control group (n = 62) | p-value | |
|---|---|---|---|---|
ESR (mm/h), median (range) | 8.0 (2.0–88.0) | 7.5 (2.0–64.0) | 7.0 (2.0–31.0) | 0.124 |
CRP (mg/l), median (range) | 0.6 (0.1–32.0) | 0.9 (0.1–25.6) | 0.5 (0.1–9.9) | 0.083 |
Hb (g/dl), mean (SD) | 12.8 (1.3) | 13.2 (0.8) | 13.2 (1.2) | 0.088 |
PLT/ µl, median (range) | 325000.0 (178000.0-524000.0) | 287500.0 (151000.0-494000.0) | 289500.0 (176000.0-522000.0) | 0.034 |
WBC/µl, median (range) | 6735.0 (3249.0-13160.0) | 6735.0 (3530.0-10110.0) | 7095.0 (4390.0-14420.0) | 0.169 |
Neutrophils/µl, median (range) | 3140.0 (375.0-9370.0) | 2795.0 (1070.0-6930.0) | 3255.0 (1430.0-7850.0) | 0.199 |
Lymphocytes/µl, median (range) | 2825.0 (1029.0-6580.0) | 2550.0 (760.0-5280.0) | 2810.0 (1070.0-7400.0) | 0.500 |
Ferritin (ng/mL), median (range) | 21.8 (1.0-133.0) | 24.6 (2.0–83.0) | 37.1 (6.0-110.0) | 0.023 |
Albumin (g/dl), mean (SD) | 4.2 (0.2) | 4.4 (0.2) | 4.3 (0.2) | < 0.001 |
CAR, median (range) | 0.1 (0.0-7.7) | 0.2 (0.0-5.6) | 0.1 (0.0-2.3) | 0.103 |
PLR, median (range) | 110.8 (55.8-319.7) | 110.3 (52.6-269.7) | 108.7 (46.1-259.8) | 0.921 |
NLR, median (range) | 1.2 (0.1–4.5) | 1.1 (0.3–4.3) | 1.1 (0.3–4.2) | 0.797 |